$CLGN

COLLPLANT APPOINTS DR. RUTI BEN SHLOMI TO ITS BOARD OF DIRECTORS FOLLOWING CLOSING OF LIGHTSOLVER ACQUISITION

CollPlant (CLGN) appointed Dr. Ruti Ben Shlomi, CEO of LightSolver, to its board after acquiring LightSolver. Ben Shlomi brings expertise in photonic computing, aiming to commercialize LightSolver's Laser Processing Unit (LPU) technology. CollPlant is diversifying into high-performance computing while continuing its biotech focus.

Original reporting
Published Sep 4, 2026, 12:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 4, 2026, 1:35 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
COLLPLANT APPOINTS DR. RUTI BEN SHLOMI TO ITS BOARD OF DIRECTORS FOLLOWING CLOSING OF LIGHTSOLVER ACQUISITION — source image
Decision brief

The 30-second read

$CLGNBullishMed
01

Why it matters

The acquisition creates a new business line for CollPlant, potentially unlocking new markets in aerospace, defense, and AI while raising integration and focus risks.

02

Market read

First‑report of acquisition completion and board appointment, likely to move CLGN stock as investors assess diversification benefits.

03

What to watch

Integration costs, need for substantial capital to scale photonic hardware, and potential regulatory scrutiny in defense applications.

Relevance 7/10Novelty 7/10Timing: effective immediately

Background

CollPlant, a Nasdaq‑listed biotech firm, announced the closing of its acquisition of LightSolver, a private photonic computing startup, and added LightSolver's CEO to its board.

Company-level read

Ticker impact

$CLGNBullishHigh confidence
Context

CollPlant completed its acquisition of LightSolver and appointed LightSolver CEO to its board, a fresh corporate event.

Expected impact

Potential short‑term upside as investors price in diversification, with volatility as integration risks are assessed.

Evidence & confidence

M&A completions typically trigger price moves; the added high‑performance computing segment is a new revenue stream.

Market effects

Highlights convergence of biotech and deep‑tech computing, may spur interest in other biotech firms exploring hardware partnerships.

Adds to Israeli tech M&A activity, modest effect on regional tech indices.

Limited to investors tracking CollPlant and niche photonic computing sector.

Counterpoint

The diversification could distract management from core biotech pipeline, risking execution and margin pressure.

Key entities

  • CollPlant Biotechnologies Ltd.

    Nasdaq‑listed biotech firm expanding into photonic computing.

  • LightSolver Ltd.

    Private photonic computing startup acquired by CollPlant.

  • Dr. Ruti Ben Shlomi

    CEO of LightSolver, newly appointed to CollPlant's board.

Related articles

$CLGNHighAI 8/10

CollPlant Is Acquiring LightSolver- Enters Supercomputing And Photonic Computing Markets

CollPlant (CLGN) is acquiring LightSolver, a developer of photonic computing technology. LightSolver's Laser Processing Unit (LPU) aims to address computational speed and energy challenges. The deal includes upfront shares, warrants, and milestone-based payments. LightSolver is working with partners like Boeing (BA) to validate its technology, targeting commercial availability by 2028.

$CLGNHighAI 8/10

COLLPLANT IS ACQUIRING LIGHTSOLVER- ENTERS SUPERCOMPUTING AND PHOTONIC COMPUTING MARKETS

CollPlant (Nasdaq: CLGN) is acquiring LightSolver, a company developing photonic computing technology. LightSolver's Laser Processing Unit (LPU) aims to address speed and energy limitations of semiconductor-based computing. The acquisition includes equity and milestone-based warrants. LightSolver is partnering with Boeing (NYSE: BA) and other global leaders for commercial validation. The deal is expected to close this week.

$CLGNMedAI 9/10

CollPlant Biotechnologies (NASDAQ:CLGN) Issues Earnings Results

CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly EPS of -$0.23, slightly above analysts’ -$0.24 consensus, according to Zacks. Revenue was $0.07 million versus an expected $0.46 million. The stock opened at $0.40 and was down 0.7%. MarketBeat data shows a $11.50 consensus target and an average “Hold” rating.

$BSPHighAI 8/10

Bending Spoons S.p.A.: Bending Spoons completes the acquisition of Airtable

Bending Spoons S.p.A. (BSP) completed its acquisition of Airtable, a platform used by 500,000+ organizations. The all-cash deal adds Airtable to Bending Spoons' portfolio. Bending Spoons plans to invest in Airtable's product, support, and marketing. Airtable's co-founder expressed confidence in Bending Spoons' resources. The acquisition was advised by Goldman Sachs, J.P. Morgan, and others.

COLLPLANT APPOINTS DR. RUTI BEN SHLOMI TO ITS BOARD OF DIRECTORS FOLLOWING CLOSING OF LIGHTSOLVER ACQUISITION — alphai